|
| 36138932 | Biomarker Genes Discovery of Alzheimer's Disease by Multi-Omics-Based Gene Regulatory Network Construction of Microglia. | Brain Sciences | 2022 |
| 23149563 | Heredity and cardiometabolic risk: naturally occurring polymorphisms in the human neuropeptide Y(2) receptor promoter disrupt multiple transcriptional response motifs. | J Hypertens | 2013 |
| 24391727 | Heritable influence of DBH on adrenergic and renal function: twin and disease studies. | PLoS One | 2013 |
| 21918574 | Genetic variation within a metabolic motif in the chromogranin a promoter: pleiotropic influence on cardiometabolic risk traits in twins. | Am J Hypertens | 2012 |
| 21551321 | Proteomic analysis yields an unexpected trans-acting point in control of the human sympathochromaffin phenotype. | Circ Cardiovasc Genet | 2011 |
| 21104344 | Catecholamine storage vesicles: role of core protein genetic polymorphisms in hypertension. | Curr Hypertens Rep | 2011 |
| 20814407 | Human dopamine β-hydroxylase promoter variant alters transcription in chromaffin cells, enzyme secretion, and blood pressure. | Am J Hypertens | 2011 |
| 20204374 | Conserved regulatory motifs at phenylethanolamine N-methyltransferase (PNMT) are disrupted by common functional genetic variation: an integrated computational/experimental approach. | Mamm Genome | 2010 |
| 21061160 | Naturally occurring genetic variants in human chromogranin A (CHGA) associated with hypertension as well as hypertensive renal disease. | Cell Mol Neurobiol | 2010 |
| 20009769 | Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. | J Hypertens | 2010 |
| 19820027 | Peptide YY (PYY) gene polymorphisms in the 3'-untranslated and proximal promoter regions regulate cellular gene expression and PYY secretion and metabolic syndrome traits in vivo. | J Clin Endocrinol Metab | 2009 |
| 28199513 | Peptide YY (PYY) Gene Polymorphisms in the 3'-Untranslated Region and Proximal Promoter Regions Regulate Cellular Gene Expression and PYY Secretion and Metabolic Syndrome Traits in Vivo. | Endocr Rev | 2009 |
| 18235090 | Chromogranin A polymorphisms are associated with hypertensive renal disease. | J Am Soc Nephrol | 2008 |
| 19120120 | Adrenergic polymorphism and the human stress response. | Ann N Y Acad Sci | 2008 |
| 19017515 | Naturally occurring human genetic variation in the 3'-untranslated region of the secretory protein chromogranin A is associated with autonomic blood pressure regulation and hypertension in a sex-dependent fashion. | J Am Coll Cardiol | 2008 |
| 18432188 | Common genetic variants in the chromogranin A promoter alter autonomic activity and blood pressure. | Kidney Int | 2008 |
| 17718510 | Biogenesis of the secretory granule: chromogranin A coiled-coil structure results in unusual physical properties and suggests a mechanism for granule core condensation. | Biochemistry | 2007 |
| 17698732 | Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo. | Circulation | 2007 |
| 17211240 | C-reactive protein, an 'intermediate phenotype' for inflammation: human twin studies reveal heritability, association with blood pressure and the metabolic syndrome, and the influence of common polymorphism at catecholaminergic/beta-adrenergic pathway loci. | J Hypertens | 2007 |
| 17584765 | An ancestral variant of Secretogranin II confers regulation by PHOX2 transcription factors and association with hypertension. | Hum Mol Genet | 2007 |
| 17353515 | Renal albumin excretion: twin studies identify influences of heredity, environment, and adrenergic pathway polymorphism. | Hypertension | 2007 |
| 17438154 | Catecholamine release-inhibitory peptide catestatin (chromogranin A(352-372)): naturally occurring amino acid variant Gly364Ser causes profound changes in human autonomic activity and alters risk for hypertension. | Circulation | 2007 |
| 17438153 | Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. | Circulation | 2007 |
| 17026486 | Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin. | Diabetes Obes Metab | 2006 |
| 16164626 | Analyses of coding region polymorphisms in apical and basolateral human organic anion transporter (OAT) genes [OAT1 (NKT), OAT2, OAT3, OAT4, URAT (RST)]. | Kidney Int | 2005 |
| 15920038 | Genetic variation at the human alpha2B-adrenergic receptor locus: role in blood pressure variation and yohimbine response. | Hypertension | 2005 |
| 15956083 | Pancreastatin: multiple actions on human intermediary metabolism in vivo, variation in disease, and naturally occurring functional genetic polymorphism. | J Clin Endocrinol Metab | 2005 |
| 14740315 | Both rare and common polymorphisms contribute functional variation at CHGA, a regulator of catecholamine physiology. | Am J Hum Genet | 2004 |
| 15326220 | The catecholamine release-inhibitory "catestatin" fragment of chromogranin a: naturally occurring human variants with different potencies for multiple chromaffin cell nicotinic cholinergic responses. | Mol Pharmacol | 2004 |
| 15514066 | Mutation rate and predicted phenotypic target sizes in ethylnitrosourea-treated mice. | Genetics | 2004 |
| 14744289 | Gene microarray analysis of human brain arteriovenous malformations. | Neurosurgery | 2004 |
| 12649522 | Abnormal expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in brain arteriovenous malformations. | Stroke | 2003 |